Clinical trial / 2008
Maca supplementation reduced psychological symptoms and sexual dysfunction in postmenopausal women without altering hormone levels.
Fourteen postmenopausal women completed a randomized, double-blind, placebo-controlled crossover trial receiving 3.5 g/day of powdered Maca and matching placebo for 6 weeks each. No significant differences were observed in serum concentrations of estradiol, FSH, LH, or SHBG between baseline, Maca, and placebo (P > 0.05). However, Maca significantly reduced Greene Climacteric Scale scores for psychological symptoms, including anxiety, depression, and sexual dysfunction compared to baseline and placebo (P < 0.05). Yeast-based assays showed no physiologically significant estrogenic or androgenic activity in Maca extracts.
- Study type
- Randomized, double-blind, placebo-controlled crossover trial
- Who was studied
- 14 postmenopausal women
- What was measured
- Hormone concentrations (estradiol, FSH, LH, SHBG) and Greene Climacteric Scale scores
THE PAPER
Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content.
Brooks NA, Wilcox G, Walker KZ, Ashton JF, Cox MB, Stojanovska L. Menopause, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.